- VIM0423, a potential first-in-class oral medicine for isolated dystonia, is currently being studied in a Phase 1 clinical trial; Phase 2 planned for fourth quarter of 2025 CAMBRIDGE, Mass., May 29, ...

Dystonias are potentially disabling neurological conditions that can greatly affect quality of life. Effective treatments are sparse, with botulinum toxin (Botox) injections into the affected muscles ...

When we think of movement disorders, the tremors associated with Parkinson’s disease are probably what first spring to mind. However, there are other equally debilitating and much less well-known ...

Sodium oxybate provided temporary relief for laryngeal dystonia patients who were alcohol-responsive. The neurologic disorder causes laryngeal muscle spasms, leading to a chronically strained voice.

Dystonia is a movement disorder that causes muscles to contract involuntarily, often leading to repetitive or twisting movements in different parts of the body. While the condition is not typically ...

Sodium oxybate is the first oral treatment for laryngeal dystonia to show efficacy at providing temporary relief for debilitating symptoms that impact speaking, according to the results of a Mass Eye ...

An artificial intelligence tool called DystoniaBoTXNet predicted which patients with dystonia would benefit from botulinum toxin injections with 96.3% accuracy. DystoniaBoTXNet could be a tool to aid ...

- VIM0423, a potential first-in-class oral medicine for isolated dystonia, is currently being studied in a Phase 1 clinical trial; Phase 2 planned for fourth quarter of 2025 ...